Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Jun;38(6):1211–1218. doi: 10.1128/aac.38.6.1211

Clinical relevance of antibiotic-induced endotoxin release.

J M Prins 1, S J van Deventer 1, E J Kuijper 1, P Speelman 1
PMCID: PMC188188  PMID: 8092816

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almdahl S. M., Osterud B. Effect of antibiotics on gram-negative sepsis in the rat. Lack of endotoxin burst. Acta Chir Scand. 1987 Apr;153(4):283–286. [PubMed] [Google Scholar]
  2. Andersen B. M., Solberg O., Bryn K., Frøholm L. O., Gaustad P., Høiby E. A., Kristiansen B. E., Bøvre K. Endotoxin liberation from Neisseria meningitidis isolated from carriers and clinical cases. Scand J Infect Dis. 1987;19(4):409–419. doi: 10.3109/00365548709021673. [DOI] [PubMed] [Google Scholar]
  3. Andersen B. M., Solberg O. Effect of benzylpenicillin in mice infected with endotoxin-liberating or non-liberating variant strains of Neisseria meningitidis. Scand J Infect Dis. 1984;16(3):257–266. doi: 10.3109/00365548409070398. [DOI] [PubMed] [Google Scholar]
  4. Arditi M., Ables L., Yogev R. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J Infect Dis. 1989 Dec;160(6):1005–1011. doi: 10.1093/infdis/160.6.1005. [DOI] [PubMed] [Google Scholar]
  5. Arditi M., Kabat W., Yogev R. Antibiotic-induced bacterial killing stimulates tumor necrosis factor-alpha release in whole blood. J Infect Dis. 1993 Jan;167(1):240–244. doi: 10.1093/infdis/167.1.240. [DOI] [PubMed] [Google Scholar]
  6. Artenstein A. W., Cross A. S. Inhibition of endotoxin reactivity by aminoglycosides. J Antimicrob Chemother. 1989 Nov;24(5):826–828. doi: 10.1093/jac/24.5.826-a. [DOI] [PubMed] [Google Scholar]
  7. Baldwin G., Alpert G., Caputo G. L., Baskin M., Parsonnet J., Gillis Z. A., Thompson C., Siber G. R., Fleisher G. R. Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins. J Infect Dis. 1991 Sep;164(3):542–549. doi: 10.1093/infdis/164.3.542. [DOI] [PubMed] [Google Scholar]
  8. Bannatyne R. M., Harnett N. M., Lee K. Y., Biggar W. D. Inhibition of the biologic effects of endotoxin on neutrophils by polymyxin B sulfate. J Infect Dis. 1977 Oct;136(4):469–474. doi: 10.1093/infdis/136.4.469. [DOI] [PubMed] [Google Scholar]
  9. Bingen E., Goury V., Bennani H., Lambert-Zechovsky N., Aujard Y., Darbord J. C. Bactericidal activity of beta-lactams and amikacin against Haemophilus influenzae: effect on endotoxin release. J Antimicrob Chemother. 1992 Aug;30(2):165–172. doi: 10.1093/jac/30.2.165. [DOI] [PubMed] [Google Scholar]
  10. Bone R. C. The pathogenesis of sepsis. Ann Intern Med. 1991 Sep 15;115(6):457–469. doi: 10.7326/0003-4819-115-6-457. [DOI] [PubMed] [Google Scholar]
  11. Brandtzaeg P., Kierulf P., Gaustad P., Skulberg A., Bruun J. N., Halvorsen S., Sørensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989 Feb;159(2):195–204. doi: 10.1093/infdis/159.2.195. [DOI] [PubMed] [Google Scholar]
  12. Burroughs M., Cabellos C., Prasad S., Tuomanen E. Bacterial components and the pathophysiology of injury to the blood-brain barrier: does cell wall add to the effects of endotoxin in gram-negative meningitis? J Infect Dis. 1992 Jun;165 (Suppl 1):S82–S85. doi: 10.1093/infdis/165-supplement_1-s82. [DOI] [PubMed] [Google Scholar]
  13. Cadieux J. E., Kuzio J., Milazzo F. H., Kropinski A. M. Spontaneous release of lipopolysaccharide by Pseudomonas aeruginosa. J Bacteriol. 1983 Aug;155(2):817–825. doi: 10.1128/jb.155.2.817-825.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cameron D. J., Churchill W. H. Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS). J Immunol. 1980 Feb;124(2):708–712. [PubMed] [Google Scholar]
  15. Cohen J., Aslam M., Pusey C. D., Ryan C. J. Protection from endotoxemia: a rat model of plasmapheresis and specific adsorption with polymyxin B. J Infect Dis. 1987 Apr;155(4):690–695. doi: 10.1093/infdis/155.4.690. [DOI] [PubMed] [Google Scholar]
  16. Cohen J., McConnell J. S. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur J Clin Microbiol. 1986 Feb;5(1):13–17. doi: 10.1007/BF02013454. [DOI] [PubMed] [Google Scholar]
  17. Cooperstock M. S. Inactivation of endotoxin by polymyxin B. Antimicrob Agents Chemother. 1974 Oct;6(4):422–425. doi: 10.1128/aac.6.4.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Corrigan J. J., Jr, Bell B. M. Endotoxin-induced intravascular coagulation: prevention with polymyxin B sulfate. J Lab Clin Med. 1971 May;77(5):802–810. [PubMed] [Google Scholar]
  19. Corrigan J. J., Jr, Kiernat J. F. Effect of polymyxin B sulfate on endotoxin activity in a gram-negative septicemia model. Pediatr Res. 1979 Jan;13(1):48–51. doi: 10.1203/00006450-197901000-00011. [DOI] [PubMed] [Google Scholar]
  20. Danner R. L., Joiner K. A., Rubin M., Patterson W. H., Johnson N., Ayers K. M., Parrillo J. E. Purification, toxicity, and antiendotoxin activity of polymyxin B nonapeptide. Antimicrob Agents Chemother. 1989 Sep;33(9):1428–1434. doi: 10.1128/aac.33.9.1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Danner R. L., Natanson C., Elin R. J., Hosseini J. M., Banks S., MacVittie T. J., Parrillo J. E. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest. 1990 Dec;98(6):1480–1487. doi: 10.1378/chest.98.6.1480. [DOI] [PubMed] [Google Scholar]
  22. Dofferhoff A. S., Esselink M. T., de Vries-Hospers H. G., van Zanten A., Bom V. J., Weits J., Vellenga E. The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytes. J Antimicrob Chemother. 1993 Mar;31(3):373–384. doi: 10.1093/jac/31.3.373. [DOI] [PubMed] [Google Scholar]
  23. Dofferhoff A. S., Nijland J. H., de Vries-Hospers H. G., Mulder P. O., Weits J., Bom V. J. Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study. Scand J Infect Dis. 1991;23(6):745–754. doi: 10.3109/00365549109024303. [DOI] [PubMed] [Google Scholar]
  24. Elsbach P., Weiss J. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology. 1993 Apr;187(3-5):417–429. doi: 10.1016/S0171-2985(11)80354-2. [DOI] [PubMed] [Google Scholar]
  25. Eng R. H., Smith S. M., Fan-Havard P., Ogbara T. Effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn Microbiol Infect Dis. 1993 Mar-Apr;16(3):185–189. doi: 10.1016/0732-8893(93)90109-k. [DOI] [PubMed] [Google Scholar]
  26. Flynn P. M., Shenep J. L., Gigliotti F., Davis D. S., Hildner W. K. Immunolabeling of lipopolysaccharide liberated from antibiotic-treated Escherichia coli. Infect Immun. 1988 Oct;56(10):2760–2762. doi: 10.1128/iai.56.10.2760-2762.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Flynn P. M., Shenep J. L., Stokes D. C., Fairclough D., Hildner W. K. Polymyxin B moderates acidosis and hypotension in established, experimental gram-negative septicemia. J Infect Dis. 1987 Nov;156(5):706–712. doi: 10.1093/infdis/156.5.706. [DOI] [PubMed] [Google Scholar]
  28. Flynn P. M., Shenep J. L., Stokes D. C., Hildner W. K., Mackert P. W., Snellgrove R. L., Rehg J. E. Effect of methylprednisolone on bacterial clearance and endotoxin liberation during experimental sepsis induced by gram-negative bacteria. Infect Immun. 1986 Apr;52(1):26–30. doi: 10.1128/iai.52.1.26-30.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Focà A., Matera G., Berlinghieri M. C., Liberto M. C., De Sarro G. B. Teicoplanin reduces in-vitro reactivity and murine lethality of Salmonella minnesota R595 lipopolysaccharide. J Antimicrob Chemother. 1992 Apr;29(4):443–446. doi: 10.1093/jac/29.4.443. [DOI] [PubMed] [Google Scholar]
  30. Focà A., Matera G., Iannello D., Berlinghieri M. C., Liberto M. C. Aminoglycosides modify the in vitro metachromatic reaction and murine generalized Shwartzman phenomenon induced by Salmonella minnesota R595 lipopolysaccharide. Antimicrob Agents Chemother. 1991 Oct;35(10):2161–2164. doi: 10.1128/aac.35.10.2161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Freudenberg M. A., Galanos C. The metabolic fate of endotoxins. Prog Clin Biol Res. 1988;272:63–75. [PubMed] [Google Scholar]
  32. Friedland I. R., Jafari H., Ehrett S., Rinderknecht S., Paris M., Coulthard M., Saxen H., Olsen K., McCracken G. H., Jr Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis. J Infect Dis. 1993 Sep;168(3):657–662. doi: 10.1093/infdis/168.3.657. [DOI] [PubMed] [Google Scholar]
  33. From A. H., Fong J. S., Good R. A. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs. Infect Immun. 1979 Mar;23(3):660–664. doi: 10.1128/iai.23.3.660-664.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Goto H., Nakamura S. Liberation of endotoxin from Escherichia coli by addition of antibiotics. Jpn J Exp Med. 1980 Feb;50(1):35–43. [PubMed] [Google Scholar]
  35. Hanberger H., Nilsson L. E., Kihlström E., Maller R. Postantibiotic effect of beta-lactam antibiotics on Escherichia coli evaluated by bioluminescence assay of bacterial ATP. Antimicrob Agents Chemother. 1990 Jan;34(1):102–106. doi: 10.1128/aac.34.1.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Hopkin D. A. Frapper fort ou frapper doucement: a gram-negative dilemma. Lancet. 1978 Dec 2;2(8101):1193–1194. [PubMed] [Google Scholar]
  37. Hughes B., Madan B. R., Parratt J. R. Polymyxin B sulphate protects cats against the haemodynamic and metabolic effects of E. coli endotoxin. Br J Pharmacol. 1981 Nov;74(3):701–707. doi: 10.1111/j.1476-5381.1981.tb10481.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Hurley J. C. Antibiotic-induced release of endotoxin: a reappraisal. Clin Infect Dis. 1992 Nov;15(5):840–854. doi: 10.1093/clind/15.5.840. [DOI] [PubMed] [Google Scholar]
  39. Hurley J. C., Louis W. J., Tosolini F. A., Carlin J. B. Antibiotic-induced release of endotoxin in chronically bacteriuric patients. Antimicrob Agents Chemother. 1991 Nov;35(11):2388–2394. doi: 10.1128/aac.35.11.2388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ishiguro E. E., Vanderwel D., Kusser W. Control of lipopolysaccharide biosynthesis and release by Escherichia coli and Salmonella typhimurium. J Bacteriol. 1986 Oct;168(1):328–333. doi: 10.1128/jb.168.1.328-333.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Issekutz A. C., Bhimji S., Bortolussi R. Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury. Infect Immun. 1982 May;36(2):548–557. doi: 10.1128/iai.36.2.548-557.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Jackson J. J., Kropp H. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis. 1992 Jun;165(6):1033–1041. doi: 10.1093/infdis/165.6.1033. [DOI] [PubMed] [Google Scholar]
  43. Kreger B. E., Craven D. E., McCabe W. R. Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med. 1980 Mar;68(3):344–355. doi: 10.1016/0002-9343(80)90102-3. [DOI] [PubMed] [Google Scholar]
  44. Kusser W. C., Ishiguro E. E. Effects of aminoglycosides and spectinomycin on the synthesis and release of lipopolysaccharide by Escherichia coli. Antimicrob Agents Chemother. 1988 Aug;32(8):1247–1250. doi: 10.1128/aac.32.8.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lopes J., Inniss W. E. Electron microscopy of effect of polymyxin on Escherichia coli lipopolysaccharide. J Bacteriol. 1969 Nov;100(2):1128–1129. doi: 10.1128/jb.100.2.1128-1130.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Marra M. N., Wilde C. G., Collins M. S., Snable J. L., Thornton M. B., Scott R. W. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol. 1992 Jan 15;148(2):532–537. [PubMed] [Google Scholar]
  47. Mathison J. C., Ulevitch R. J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol. 1979 Nov;123(5):2133–2143. [PubMed] [Google Scholar]
  48. Mattsby-Baltzer I., Lindgren K., Lindholm B., Edebo L. Endotoxin shedding by enterobacteria: free and cell-bound endotoxin differ in Limulus activity. Infect Immun. 1991 Feb;59(2):689–695. doi: 10.1128/iai.59.2.689-695.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. McConnell J. S., Cohen J. Release of endotoxin from Escherichia coli by quinolones. J Antimicrob Chemother. 1986 Dec;18(6):765–766. doi: 10.1093/jac/18.6.765. [DOI] [PubMed] [Google Scholar]
  50. Mellado M. C., Rodríguez-Contreras R., Mariscal A., Luna J. D., Delgado Rodríguez M., Galvez-Vargas R. Effect of penicillin and chloramphenicol on the growth and endotoxin release by N. meningitidis. Epidemiol Infect. 1991 Apr;106(2):283–288. doi: 10.1017/s0950268800048421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Mendelman P. M., Chaffin D. O., Kalaitzoglou G. Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae. J Antimicrob Chemother. 1990 Apr;25(4):525–534. doi: 10.1093/jac/25.4.525. [DOI] [PubMed] [Google Scholar]
  52. Mertsola J., Ramilo O., Mustafa M. M., Sáez-Llorens X., Hansen E. J., McCracken G. H., Jr Release of endotoxin after antibiotic treatment of Gram-negative bacterial meningitis. Pediatr Infect Dis J. 1989 Dec;8(12):904–906. doi: 10.1097/00006454-198912000-00036. [DOI] [PubMed] [Google Scholar]
  53. Moore R. A., Bates N. C., Hancock R. E. Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin. Antimicrob Agents Chemother. 1986 Mar;29(3):496–500. doi: 10.1128/aac.29.3.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Mustafa M. M., Mertsola J., Ramilo O., Sáez-Llorens X., Risser R. C., McCracken G. H., Jr Increased endotoxin and interleukin-1 beta concentrations in cerebrospinal fluid of infants with coliform meningitis and ventriculitis associated with intraventricular gentamicin therapy. J Infect Dis. 1989 Nov;160(5):891–895. doi: 10.1093/infdis/160.5.891. [DOI] [PubMed] [Google Scholar]
  55. Mustafa M. M., Ramilo O., Mertsola J., Risser R. C., Beutler B., Hansen E. J., McCracken G. H., Jr Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis. 1989 Nov;160(5):818–825. doi: 10.1093/infdis/160.5.818. [DOI] [PubMed] [Google Scholar]
  56. Natanson C., Danner R. L., Reilly J. M., Doerfler M. L., Hoffman W. D., Akin G. L., Hosseini J. M., Banks S. M., Elin R. J., MacVittie T. J. Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol. 1990 Nov;259(5 Pt 2):H1440–H1447. doi: 10.1152/ajpheart.1990.259.5.H1440. [DOI] [PubMed] [Google Scholar]
  57. Neu H. C. Carbapenems: special properties contributing to their activity. Am J Med. 1985 Jun 7;78(6A):33–40. doi: 10.1016/0002-9343(85)90099-3. [DOI] [PubMed] [Google Scholar]
  58. Neu H. C. Penicillin-binding proteins and role of amdinocillin in causing bacterial cell death. Am J Med. 1983 Aug 29;75(2A):9–20. doi: 10.1016/0002-9343(83)90089-x. [DOI] [PubMed] [Google Scholar]
  59. Neu H. C. Relation of structural properties of beta-lactam antibiotics to antibacterial activity. Am J Med. 1985 Aug 9;79(2A):2–13. doi: 10.1016/0002-9343(85)90254-2. [DOI] [PubMed] [Google Scholar]
  60. Palmer J. D., Rifkind D. Neutralization of the hemodynamic effects of endotoxin by polymyxin B. Surg Gynecol Obstet. 1974 May;138(5):755–759. [PubMed] [Google Scholar]
  61. Røkke O., Revhaug A., Osterud B., Giercksky K. E. Increased plasma levels of endotoxin and corresponding changes in circulatory performance in a porcine sepsis model: the effect of antibiotic administration. Prog Clin Biol Res. 1988;272:247–262. [PubMed] [Google Scholar]
  62. Schumann R. R., Leong S. R., Flaggs G. W., Gray P. W., Wright S. D., Mathison J. C., Tobias P. S., Ulevitch R. J. Structure and function of lipopolysaccharide binding protein. Science. 1990 Sep 21;249(4975):1429–1431. doi: 10.1126/science.2402637. [DOI] [PubMed] [Google Scholar]
  63. Shenep J. L., Barton R. P., Mogan K. A. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis. 1985 Jun;151(6):1012–1018. doi: 10.1093/infdis/151.6.1012. [DOI] [PubMed] [Google Scholar]
  64. Shenep J. L., Feldman S., Thornton D. Evaluation for endotoxemia in patients receiving penicillin therapy for secondary syphilis. JAMA. 1986 Jul 18;256(3):388–390. [PubMed] [Google Scholar]
  65. Shenep J. L., Gigliotti F., Davis D. S., Hildner W. K. Reactivity of antibodies to core glycolipid with gram-negative bacteria. Rev Infect Dis. 1987 Sep-Oct;9 (Suppl 5):S639–S643. doi: 10.1093/clinids/9.supplement_5.s639. [DOI] [PubMed] [Google Scholar]
  66. Shenep J. L., Mogan K. A. Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis. J Infect Dis. 1984 Sep;150(3):380–388. doi: 10.1093/infdis/150.3.380. [DOI] [PubMed] [Google Scholar]
  67. Simon D. M., Koenig G., Trenholme G. M. Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J Infect Dis. 1991 Oct;164(4):800–802. doi: 10.1093/infdis/164.4.800. [DOI] [PubMed] [Google Scholar]
  68. Spratt B. G., Cromie K. D. Penicillin-binding proteins of gram-negative bacteria. Rev Infect Dis. 1988 Jul-Aug;10(4):699–711. doi: 10.1093/clinids/10.4.699. [DOI] [PubMed] [Google Scholar]
  69. Stokes D. C., Shenep J. L., Fishman M., Hildner W. K., Bysani G. K., Rufus K. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-alpha from alveolar macrophages. J Infect Dis. 1989 Jul;160(1):52–57. doi: 10.1093/infdis/160.1.52. [DOI] [PubMed] [Google Scholar]
  70. Taylor P. W. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev. 1983 Mar;47(1):46–83. doi: 10.1128/mr.47.1.46-83.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Tesh V. L., Vukajlovich S. W., Morrison D. C. Endotoxin interactions with serum proteins relationship to biological activity. Prog Clin Biol Res. 1988;272:47–62. [PubMed] [Google Scholar]
  72. Tomasz A. Penicillin-binding proteins and the antibacterial effectiveness of beta-lactam antibiotics. Rev Infect Dis. 1986 Jul-Aug;8 (Suppl 3):S260–S278. doi: 10.1093/clinids/8.supplement_3.s260. [DOI] [PubMed] [Google Scholar]
  73. Tuomanen E., Gilbert K., Tomasz A. Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli. Antimicrob Agents Chemother. 1986 Nov;30(5):659–663. doi: 10.1128/aac.30.5.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Täuber M. G., Shibl A. M., Hackbarth C. J., Larrick J. W., Sande M. A. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis. 1987 Sep;156(3):456–462. doi: 10.1093/infdis/156.3.456. [DOI] [PubMed] [Google Scholar]
  75. Van Den Berg C., de Neeling A. J., Schot C. S., Hustinx W. N., Wemer J., de Wildt D. J. Delayed antibiotic-induced lysis of Escherichia coli in vitro is correlated with enhancement of LPS release. Scand J Infect Dis. 1992;24(5):619–627. doi: 10.3109/00365549209054648. [DOI] [PubMed] [Google Scholar]
  76. Walterspiel J. N., Kaplan S. L., Mason E. O., Jr, Walterspiel J. W. Protective effect of subinhibitory polymyxin B alone and in combination with ampicillin for overwhelming Haemophilus influenzae type B infection in the infant rat: evidence for in vivo and in vitro release of free endotoxin after ampicillin treatment. Pediatr Res. 1986 Mar;20(3):237–241. doi: 10.1203/00006450-198603000-00008. [DOI] [PubMed] [Google Scholar]
  77. Warren H. S., Kania S. A., Siber G. R. Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide. Antimicrob Agents Chemother. 1985 Jul;28(1):107–112. doi: 10.1128/aac.28.1.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Wispelwey B., Lesse A. J., Hansen E. J., Scheld W. M. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. J Clin Invest. 1988 Oct;82(4):1339–1346. doi: 10.1172/JCI113736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990 Sep 21;249(4975):1431–1433. doi: 10.1126/science.1698311. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES